Search | TVST | ARVO Journals

tvst

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (4)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (4)
Translational Vision Science & Technology (1)

Article Type

ARVO Annual Meeting Abstract (4)
Articles (1)

Topics

Eye Anatomy and Disorders (1)
Translational Research (1)
Vitreous Disorders (1)

Tags

angiogenesis inhibitors (1)
diabetes mellitus (1)
hyperprolactinemia (1)
placebos (1)
prolactin (1)
proliferative diabetic retinopathy (1)
vitreous body (1)

Specify Date Range

From: To: Apply

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

VIAN-c4551 delivered in eye drops reaches high therapeutic concentrations in the back of the eye of rabbits.

Magdalena Zamora; Juan Pablo Robles; Elva Adán-Castro; Lourdes Siqueiros-Márquez; Jose Fernando García-Rodrigo; Daniela Granados-Carrasco; Thomas Bertsch; Jakob Triebel; Gonzalo Martinez de la Escalera; Carmen Clapp

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3146.

ARVO Annual Meeting Abstract June 2024

VIAN-c4551 is a potent topical inhibitor of VEGF and Ang-2 that reduces macular edema and angiogenesis in vascular retinopathies.

Juan Pablo Robles; Magdalena Zamora; Lourdes Siqueiros-Márquez; Elva Adán-Castro; Jose Fernando García-Rodrigo; Daniela Granados-Carrasco; Thomas Bertsch; Jakob Triebel; Gonzalo Martinez de la Escalera; Carmen Clapp

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4933.

ARVO Annual Meeting Abstract June 2024

VIAN-c4551 inhibits oxygen-induced retinopathy in mice

Lourdes Montserrat SIQUEIROS; Jose Fernando García-Rodrigo; Elva Adán Castro; Daniela Granados-Carrasco; Juan Pablo Robles; Magdalena Zamora; Xarubet Ruiz Herrera; Thomas Bertsch; Jakob Triebel; Gonzalo Martinez de la Escalera; Carmen Clapp

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6287.

ARVO Annual Meeting Abstract June 2024

VIAN-c4551 in eye drops inhibits the excessive retinal vasopermeability induced by VEGF and diabetes in rodents

Elva Adán Castro; Juan Pablo Robles; Magdalena Zamora; Lourdes Siqueiros-Márquez; Daniela Granados-Carrasco; Jose Fernando García-Rodrigo; Marlon García-Roa; Ellery López-Star; Thomas Bertsch; Jakob Triebel; Gonzalo Martinez de la Escalera; Carmen Clapp

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6236.

Articles August 2020

Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy

PDF

Carlos D. Nuñez-Amaro; Aura Ileana Moreno-Vega; Elva Adan-Castro; Magdalena Zamora; Renata Garcia-Franco; Paulina Ramirez-Neria; Marlon Garcia-Roa; Yolanda Villalpando; Juan Pablo Robles; Gabriela Ramirez-Hernandez; Mariana Lopez; Jorge Sanchez; Ellery Lopez-Star; Thomas Bertsch; Gonzalo Martinez de la Escalera; Ma. Ludivina Robles-Osorio; Jakob Triebel; Carmen Clapp
TAGS: angiogenesis inhibitors, diabetes mellitus, prolactin, vitreous body, proliferative diabetic retinopathy, hyperprolactinemia, placebos
Trans. Vis. Sci. Tech.. 2020; 9(9):27. https://doi.org/10.1167/tvst.9.9.27

« Previous

Advertisement

Follow @ARVOtvst

TVST Home
Issues
Topics
For Authors

About
- Editorial Board

Online ISSN: 2164-2591

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2024 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept